CHAIR
ENRIQUETA BOND, Ph.D. is President of the Burroughs Wellcome Fund. She received her undergraduate degree in zoology and physiology from Wellesley College, a master’s degree in genetics from the University of Virginia, and a Ph.D. in Molecular Biology and Biochemical Genetics from Georgetown University. Prior to joining the Fund, Dr. Bond was the Executive Officer of the Institute of Medicine where she spent 20 years managing programs in health and science policy. She serves on the Board of Regents for the National Library of Medicine, the Executive Committee and Board of the North Carolina Biotechnology Center, the Board of Scientific Counselors of the National Center of Infectious Diseases and the Society to Advance Research on Women’s Health. Dr. Bond is a member of the Institute of Medicine.

MEMBERS
CATHERINE M. BAASE, M.D. is the Global Director of Health Services for The Dow Chemical Company. Dr. Baase has direct responsibility for leadership and management of all Occupational Health, Epidemiology Research and Health Promotion staff and programs around the world. In addition to these roles, Dr. Baase is the driver of an integrated health vision and approach called Health and Human Performance, which spans all health activities for employees, retirees and their families. She is also involved in health policy and health issue management at Dow. Previously, Dr. Baase was the director of Health Care Strategic Planning with direct responsibility for the US health benefit plans. In addition, Dr. Baase is on the Board of Directors of the Partnership for Prevention, a national, public-private partnership dedicated to preventive health services. Dr. Baase is on the Advisory Board of The Institute for Health and Productivity, and she was co-chair of the Center for Prevention and Health Promotion of the Institute for Health and Productivity. Dr. Baase is a member of ACOEM and has been board certified in Family Practice since completing her residency at Saginaw Cooperative Hospitals where she served as chief resident. She graduated from the College of Human Medicine, Michigan State University, and also completed a post-doctoral fellowship in primary care faculty development. Before entering medical school, Dr. Baase worked as a chemist doing polymer research for Dow Chemical. She graduated summa cum laude from Saginaw Valley State University with degrees in chemistry and secondary education.

ROBERT BONOW, M.D. is Goldberg Professor of Medicine at Northwestern University Feinberg School of Medicine and Chief of the Division of Cardiology at Northwestern Memorial Hospital. He received his MD degree from the University of Pennsylvania School of Medicine. Before joining Northwestern in 1992, Dr. Bonow was Chief of the Nuclear Cardiology Section and Deputy Chief of the Cardiology Branch at the National Heart, Lung, and Blood Institute. Dr. Bonow is recognized for his research and teaching in a variety of cardiac diseases, including coronary artery disease, valvular heart disease, and heart failure. He has authored or co-authored more than 300 published papers. He serves on the editorial boards of 12 medical journals including Circulation, Journal of the American Heart Association. Dr. Bonow is President of the American Heart Association for 2002-2003. He has served on the Association’s Board of Directors since 1999. He is immediate past chairman of the American Heart Association’s Committee on Scientific Sessions Program (1998 to 2000), Council on Clinical Cardiology (1999-2001), and Clinical Science Committee (2001-2002). He also serves on the Board of Extramural Advisors of the National Heart, Lung, and Blood Institute and the Board of Trustees of the American College of Cardiology.

J. LYLE BOOTMAN, Ph.D. is Dean and Professor of Pharmacy, Medicine and Public Health at The University of Arizona College of Pharmacy. He is also the founding and Executive Director of The University of Arizona Center for Health Outcomes and PharmacoEconomic (HOPE) Research, one of the first such centers developed in the world. Dr. Bootman is a former President of the American Pharmaceutical Association. Dr. Bootman has received numerous outstanding scientific achievement awards, most notably from the American Association of Pharmaceutical Scientists and the American Pharmaceutical Association. He was also the recipient of the George Archambault Award, the highest honor given by the American Society of Consultant Pharmacists and the Latiolais Honor Medal, the highest honor in managed health care. His research regarding the outcomes of drug-related morbidity and mortality receives worldwide attention by the professional and public media. He serves as an advisor to leading pharmaceutical companies, universities, and health care organizations throughout the world. In 1998, Dr. Bootman was elected to the IOM, where he currently serves on the Board of Health Care Services.

ROBERT M. CALIFF, M.D. is Director of the Duke Clinical Research Unit, and Professor of Medicine in the Division of Cardiology and Associate Vice Chancellor for Clinical Research at the Duke University Medical Center. Dr. Califf’s research focuses on clinical and economic outcomes in chronic ischemic heart disease. He has led a number of long-term clinical trials evaluating a range of cardiovascular treatments and procedures. He is a Fellow of the American College of Cardiology, and a certified specialist in internal medicine and cardiovascular diseases. Dr. Califf has served on several Academy committees including the Roundtable on Research and Development of Drugs, Biologics, and Medical Devices.

SCOTT E. CAMPBELL, Ph.D. received his Ph.D. in Basic Biomedical Sciences in 1985. He spent 16 years in academia where his primary area of research interest was hypertension, heart failure and the renin-angiotensin system. He is the author of 36 peer-reviewed articles, 8 invited reviews and 14 book chapters. Dr. Campbell joined the American Diabetes Association in 2001 as National Vice President of Research Programs. In addition to overseeing all research-related programs at the ADA, he also is responsible for helping acquire major donations to the ADA Research Foundation.

VERONICA CATANESE, M.D. is Dean for Medical Education and Associate Professor of Medicine and Cell Biology at the New York University School of Medicine. She received her undergraduate degree from Wellsley College and her M.D. from NYU. Dr. Catanese, former President of the American Federation for Clinical Research and Irma T. Hirschl Career Scientist Awardee, is currently Editor-in-Chief of The Journal of Investigative Medicine and Director of Development of the American Federation for Medical Research Foundation. She serves as co-Chair of the NIH Physiology and Bioengineering Special Study Section, and her research interests include the biology and physiology of the IGF-I and related growth factor systems in diabetic nephropathy and heart failure.

FRANCIS CHESLEY, M.D. is Director of the Office of Research, Review, Education, and Policy at the Agency for Healthcare Research and Quality. He provides leadership in the development of health service research educational training programs, directs the agency’s research grant application peer review activities, and is responsible for the development and implementation of Agency extramural research policies and procedures. Dr. Chesley received his undergraduate degree and M.D. from Georgetown University.

WILLIAM CROWLEY Jr., M.D. is Director of Clinical Research and Chief of the Reproductive Endocrine Unit at Massachusetts General Hospital; Director of the National Center for Infertility Research, and a Professor of Medicine at Harvard University. Dr. Crowley received his undergraduate degree from Holy Cross College and his M.D. from Tufts University Medical School. He is board certified in Internal Medicine, Endocrinology, and Metabolism. He is the founder of the Academic Health Center Clinical Research Forum, and is a member of the Board of Directors and Executive Committee of FASEB. He is also the director of the National Center for Infertility Research. His research interests are: neuroendocrine control or reproduction and growth, physiology of puberty, and physiology of gonadotropin secretion.

HELEN B. DARLING is president of the National Business Group on Health (NBGH). The Business Group represents large employers' perspective on national health policy issues and provides practical solutions to its members' most important health care problems. In addition to her NBGH responsibilities, Darling currently serves as co-chair of the National Committee on Quality Assurance Committee on Performance Measure. She is also a member of the Medical Advisory Panel, Technology Evaluation Center, run by the Blue Cross Blue Shield Association; the Institute of Medicine's Board on Health Promotion and Disease Prevention; the Council on Health Care Economics and Policy; and the Board of Gaylord Rehabilitation Hospital. Prior to joining the Business Group, Darling served as Senior Consultant, Group Benefits and Health Costs for Watson Wyatt and Company. Prior to working for Watson Wyatt, Darling directed the purchasing of health benefits and disability for thousands of employees and retirees at Xerox Corporation. Darling received her master’s degree in Demography/Sociology and her bachelor’s of science degree in History/English, cum laude, from Memphis State University.

ADRIAN DOBS, M.D. is Director, Clinical Trials Unit, and is Professor and Vice-Chairperson, Department of Medicine, Clinical Research, Johns Hopkins University. Dr. Dobs received her undergraduate degree at Cornell, her M.D. at Albany Medical College, and clinical training in Internal Medicine at Montefiore Hospital in New York City. She came to Johns Hopkins for a fellowship in endocrinology where she also received a degree in Clinical Epidemiology. Dr. Dobs is presently an active investigator, particularly in the field of male gonadal function. She oversees a Clinical Trials Unit for the School of Medicine and has been very involved with developing procedures to expedite clinical investigation within the academic environment.

JOHN FEUSSNER, M.D., M.P.H. is Professor and Chairman of the Department of Medicine at the Medical University of South Carolina. He received his undergraduate degree from the University of Pennsylvania, his M.D. from the College of Medicine of the University of Vermont and his M.P.H. from the University of North Carolina. Before accepting his current position, Dr. Feussner was Chief Research and Development Officer for the Department of Veterans Affairs, overseeing the Department of Veterans Affairs research program. He is also the former Director of the Center for Health Services Research in Primary Care at the Durham VA Medical Center. He has authored or co-authored over 125 scientific publications and is a Diplomat of the American Board of Internal Medicine and is a Fellow in the American College of Physicians.

ELAINE K. GALLIN, Ph.D. is the Program Director for Medical Research at the Doris Duke Charitable Foundation (DDCF). She received her Ph.D. in Biology from the City University of New York and completed postdoctoral fellowships in Physiology at Johns Hopkins University Medical School and Columbia University Medical School. Before becoming a research administrator, she was the Chief of the Division of Cell Physiology at the Armed Forces Radiobiology Research Institute (AFRRI). As a researcher, Dr. Gallin has served on the Physiology Study Section at the NIH and other peer review panels, as well as professional committees including the Council of the Biophysical Society. In 1989, Dr. Gallin spent a year as a Congressional Science Fellow in the U.S. House of Representatives. From 1995 to 1997, she was the Deputy Director of the Office of International Health Programs in the U.S. Department of Energy.

MYRON GENEL, M.D. is a Professor of Pediatrics and Associate Dean at the Yale School of Medicine where he has directed the school's Office of Government & Community Affairs. Previously he was program director of Yale's Children's Clinical Research Center for 16 years. Dr Genel received his undergraduate degree from Moravian College and received an honorary Doctor of Science degree from Moravian in l995. He received his medical degree at the University of Pennsylvania and clinical training at Mount Sinai Hospital, NY, Johns Hopkins Hospital and Children's Hospital of Philadelphia. He has authored more than 130 scientific publications, primarily in pediatric endocrinology. Dr. Genel is a former chair of the AAMC's Council of Academic Societies and the AMA's Council on Scientific Affairs and a past president of the Association of GCRC Program Directors. He is a fellow of the American Association for the Advancement of Science, the American Academy of Pediatrics, and the Connecticut Academy of Science and Engineering where he serves as a member of the executive council.

KENNETH GETZ, M.B.A. is the President and CEO of CenterWatch, a publishing and market research company that focuses on the clinical trials industry. CenterWatch is a subsidiary of the Medical Economics Company. Mr. Getz earned his undergraduate degree from Brandeis University and an M.B.A. from Northwestern University. Prior to CenterWatch, Mr. Getz worked as a management consultant with Arthur D. Little and then with Corporate Decisions, where he assisted pharmaceutical and biotechnology companies develop and implement drug development strategies. He is a well-known speaker and has contributed book chapters and more than 100 journal articles to such publications as Scrip Magazine, Applied Clinical Trials, The Drug Information Journal, and the Medical and HealthCare MarketPlace.

LAWRENCE W. GREEN, Dr.PH. is the first permanent director of the CDC Office of Science and Extramural Research and Associate Director for Prevention Research and Academic Partnerships in CDC's PHPPO as of August 26, 2001. Most recently, he served as Acting Director of CDC's Office on Smoking and Health and director of the WHO Collaborating Center on Tobacco and Health, with responsibility for the development and coordination of CDC's global tobacco control strategy in collaboration with the World Health Organization. Prior to coming to CDC, he served as Director of the Institute of Health Promotion Research and Professor and Head of the Division of Preventive Medicine and Health Promotion, Department of Health Care and Epidemiology, at the University of British Columbia. He served as the first Director of the U.S. Office of Health Information, Health Promotion and Physical Fitness and Sports Medicine in the Office of the Assistant Secretary for Health, HHS; and as Vice President of the Kaiser Family Foundation. He has been on the public health faculties at Berkeley, Johns Hopkins, Harvard, and Texas. He currently serves on the Editorial Boards of the American Journal of Public Health, Health Education Research, Theory and Practice, the American Journal of Preventive Medicine and 12 other journals in his field. He has published extensively in the field of public health and is the coauthor (with Dr. Marshall Kreuter) of the classic text, Health Promotion Planning: An Educational and Ecological Approach, and with Judith Ottoson, Community and Population Health.

STEPHEN BENNETT JOHNSON, Ph.D. is an Associate Professor of Medical Informatics at Columbia University. He received his undergraduate degree in Computer Science from McGill University. His doctorate at New York University was also in Computer Science, specializing in natural language processing. Dr. Johnson currently serves as the director of Informatics for the Cancer Center at the Columbia-Presbyterian Medical Center, using information technology to assist in cancer care and research. He also directs the graduate degree program in Medical Informatics at Columbia. Dr. Johnson has been deeply interested in representing and managing complex data in the medical domain, of which narrative data is a vital component. This work resulted in the Clinical Data Repository at the Columbia-Presbyterian Medical Center, one of the first large-scale relational databases in medicine. This database maintains the electronic records of all patients treated by the institution. Current research explores methods of organizing large databases for clinical research (data warehousing), and machine learning techniques for analyzing such collections (data mining). Another key project supports a large-scale study of genetic and environmental factors in cancer, developing information systems for recruitment, data collection, follow-up and analysis. Finally, Dr. Johnson is conducting research on automatic linking of patient records to the medical literature to facilitate evidence-based medicine.

ANTONIA KOLOKATHIS, M.D. is Vice President, Medical Affairs, Pfizer Pharmaceuticals Group and Agouron Pharmaceuticals where she is responsible for the Worldwide Anti-infective and Pulmonary post-marketing clinical research programs and for the clinical HIV program at Agouron Pharmaceuticals. Dr. Kolokathis joined Pfizer in 1991 and prior to her current role she has held various positions with Pfizer Global Research and Development anti-infective group and has conducted multiple clinical trials in infectious diseases including trials against Legionella pneumonia, fungal infections, and HIV trials. After completion of her training at Mount Sinai in New York, she joined the Infectious Diseases faculty at Beth Israel Medical Center in New York. Her roles and responsibilities included HIV research as well as managing the inpatient and outpatient HIV research facility. Dr. Kolokathis is a member of numerous organizations including the Infectious Disease Society of America and the American Society of Microbiology.

ALLAN KORN, M.D., F.A.C.P. is the Senior Vice President and Chief Medical Officer of the Blue Cross and Blue Shield Association, a federation of independent, locally based Blue Cross and Blue Shield companies. Dr. Korn is responsible for overseeing the technological evaluation center, an independent applied health service organization that uses an evidence-based methodology for the assessment of clinical technologies. Previously, he served as Senior Vice President, Medical Affairs for Premier Health Alliance, where he developed advanced physician educational programs dealing with clinical and economic issues. Dr. Korn received his undergraduate degree and M.D. from Tufts University. He serves on the Certified American Board of Internal Medicine and the Certified American Board of Quality Assurance and Utilization Review.

DAVID KORN, M.D. is Senior Vice President for Biomedical and Health Sciences Research at the Association of American Medical Colleges. He is also vice president, dean of medicine, and professor of pathology, emeritus, Stanford University. Dr. Korn received his undergraduate degree and M.D. from Harvard University. He was a founder of the California Organ Transplant Donor Network, one of the nation’s largest Organ Procurement Organizations, and was appointed as chairman of the National Cancer Advisory Board in 1984 by Ronald Reagan, a position he held until 1991. Dr. Korn is a fellow of the American Association for the Advancement of Science and currently serves on its council. He has also served on the editorial boards of the American Journal of Pathology, The Journal of Biological Chemistry, and Human Pathology. He is a member of both the Institute of Medicine and the National Academy of Sciences.

JIM LANDO, M.D., M.P.H., F.A.C.P.M. has been Deputy Associate Director for Science for the National Center for Chronic Disease Prevention and Health Promotion at CDC since July 2002. Prior to taking this position, he was Director of the CDC Preventive Medicine Residency. Dr. Lando is a graduate of the Epidemic Intelligence Service and serves on the CDC Emergency Response Teams. He received his Sc.B. from Brown University in Neuroscience, his M.D. from Brown School of Medicine, and his M.P.H. from the University of New Mexico. Before coming to CDC, Dr. Lando was a medical epidemiologist for the New Mexico SEER cancer registry where he worked on an NCI sponsored study of community mammography performance. He has also served as Chair of the NM Advisory Committee on Cardiovascular Health. He is board certified in public health/general preventive medicine and is a fellow of the American College of Preventive Medicine.

DAVID LEPAY, M.D., Ph.D. - Bio unavailable

JOHN R. LUMPKIN, M.D., M.P.H. is the new Senior Vice President for Health Care at the Robert Wood Johnson Foundation. Prior to joining RWJ, he was the first African American to hold the position of Public Health Director in the state of Illinois. He served the third longest tenure of any director since the present agency structure was created in 1917. As director of IDPH, Dr. Lumpkin oversaw an agency of 1,300 employees located in Springfield, Chicago, seven regional offices and three laboratories who share primary responsibility for the quality of life in the state. Dr. Lumpkin’s career in public health began with his appointment in 1985 as associate director of IDPH’s Office of Health Care Regulations, which oversees the licensing, inspection and certification of health care facilities. Dr. Lumpkin received his medical degree in 1974 from Northwestern University Medical School. He trained in Emergency Medicine at the University of Chicago and earned his M.P.H. from the University of Illinois at Chicago, School of Public Health. Dr. Lumpkin is past president of the Association of State and Territorial Health Officials (ASTHO), a former member of the Board of Trustees of the Foundation for Accountability, a former Commissioner of the Pew Commission on Environmental Health, a board member of the National Forum for Health Care Quality Measurement and Reporting, a past board member of the American College of Emergency Physicians and past president of the Society of Teachers of Emergency Medicine.

RICK A. MARTINEZ, M.D. is Director of Medical Affairs for Corporate Community Relations at Johnson & Johnson. He received his A.B. at the University of North Carolina and his M.D. from Wake Forest University. Previous positions have included Director of CNS Medical Affairs at Janssen Pharmaceutical, Associate Director of the Janssen Research Foundation, and Chief of Geriatric Psychopharmacology Research with the National Institutes of Mental Health. In the past, Dr. Martinez served as Fellow to the U.S. Senate on the Special Committee on Aging as well as a technical advisor to the Federal City Shelter Infirmary in Washington, D.C. He is currently involved as an Issue Expert to the Ad Council’s Public Issues Committee. Dr. Martinez has additional experience as both an Adjunct Associate Professor with the University of Pennsylvania as well as a medical advisor to the Greater Washington Area Alzheimer’s Association.

RICHARD MURRAY, M.D. - Bio unavailable

JONATHAN PERLIN, M.D., Ph.D. - Bio unavailable

NANCY E. REAME, Ph.D., R.N. holds the Rhetaugh G. Dumas Endowed Chair at the University of Michigan School of Nursing. She is an infertility nursing specialist, reproductive physiologist, and women's health researcher who conducts studies in two major areas: the reproductive endocrinology of reproduction and menopause; and the bioethical aspects of assisted reproduction. Her current work is testing the theory that menopause starts in the brain, rather than in the ovary where the gradual loss of eggs leads to a fall in estrogen. Her additional research includes programs looking at reproductive endocrinology, menstrual cycle, menopause, infertility, gender and health, and surrogate pregnancy. Dr. Reame is a member of the Institute of Medicine. She initially studied nursing at Michigan State University and earned her master's and Ph.D. in maternity nursing and physiology at Wayne State. In 1980 she became a tenured professor at the University of Michigan.

E. ALBERT REECE, M.D., Ph.D., M.B.A. is Vice Chancellor and Dean of the University of Arkansas College of Medicine. Dr. Reece received his undergraduate degree from Long Island University, his M.D. from New York University, his Ph.D. degree in biochemistry from the University of the West Indies, and his M.B.A. degree from the Fox School of Business and Management of Temple University. He completed a residency in OB/GYN at Columbia University - Presbyterian Hospital, and a fellowship in maternal-fetal medicine at Yale University School of Medicine. He served on the faculty at Yale for 10 year and was the Chairman of the Department of Obstetrics, Gynecology and Reproductive Sciences at Temple University. Dr. Reece has published over 400 journal articles, papers, book chapters, and abstracts and 9 textbooks including Diabetes in Pregnancy; Medicine of the Fetus & Mother; and Fundamentals of Ultrasound in Obstetrics & Gynecology. He is an editor for the Journal of Maternal-Fetal Medicine and a reviewer for several other scientific journals. His research focuses on diabetes in pregnancy, birth defects and prenatal diagnosis. Dr. Reece is a member of the Institute of Medicine.

DAVID RIMOIN, M.D., Ph.D. is Professor of Pediatrics and Medicine at the University of California, Los Angeles School of Medicine and Chairman of Pediatrics and Director of the Medical Genetics-Birth Defects Center at Cedars-Sinai Medical Center. He received his M.D. from McGill University and his Ph.D. in human genetics from Johns Hopkins University. He has published over 350 papers in peer-reviewed journals and edited 11 books, including Rimoin and Emery's Principles and Practice of Medical Genetics. Dr. Rimoin was President of the American Society of Human Genetics and the Founding President of the American College of Medical Genetics and the American Board of Medical Genetics. He is currently President of the American College of Medical Genetics Foundation. He also served as the Secretary/Treasurer of the American Federation for Clinical Research and President of the Western Society for Clinical Research as well as the Western Society of Pediatric Research. Dr. Rimoin is a member of the Institute of Medicine.

PATRICIA SALBER M.D., M.B.A., F.A.C.E.P., F.A.C.P. is the Senior Medical Director of CalPERS at Blue Shield of California. Before accepting his current position, she was Medical Director for Managed Care, Health Care Initiatives for General Motors Corporation working in conjunction with The Permanente Company. Dr. Salber was also a Permanente Medical Group emergency physician for seventeen years. She earned her undergraduate degree from the University of California, Berkeley, her M.B.A. from the University of California, Irvine, and her M.D. from the University of California, San Francisco. She is board certified in emergency medicine and internal medicine and is a Fellow of the American College of Emergency Physicians and the American College of Physicians. Dr. Salber has authored or co-authored more than 20 journal articles and has produced five educational videos. She co-founded and currently serves a Co-president of Physicians for a Violence-free Society, a national non-profit organization dedicated to improving health care’s response to victims of violence. She has served on the Board of Directors of a number of physician organizations. While serving on the American College of Emergency Physicians’ Board of Directors, she played the lead role in crafting the ACEP-Kaiser Permanente agreement on emergency services. She currently serves on the Board of a for-profit biotech company, CalTag, located in the San Francisco Bay Area. Dr. Salber is a nationally recognized expert in the health aspects of domestic violence as well as managed strategies of large employers.

DAVID A. SCHEINBERG, M.D., Ph.D. is incumbent of the Vincent Astor Chair, Doris Duke Distinguished Clinical Science Professor and Chief of Leukemia at Memorial Sloan-Kettering Cancer Center. He received his undergraduate degree from Cornell University, and his M.D. and Ph.D. from the Johns Hopkins University. He trained at the New York Hospital-Cornell Medical Center. Dr. Scheinberg is board certified in internal medicine and medical oncology. He has clinical expertise in acute and chronic leukemias, immunotherapy, monoclonal antibodies, cancer vaccines, and flow cytometry. Dr. Scheinberg has authored or co-authored more than 140 scientific publications.

BERNARD SCHWETZ, D.V.M., Ph.D. is Acting Director of the Office of Human Research Protections and a Senior Research Scientist at the Food and Drug Administration and the University of Maryland at College Park, Maryland. He was the Acting Principal Deputy Commissioner of the FDA from January 20, 2001, to February 22, 2002. From September 1999 until January, 2001, he served as the Acting Deputy Commissioner of the agency. He served as Senior Advisor for Science from September 1999 until June 2000. He was Director of FDA’s National Center for Toxicological Research in Jefferson, AR, from 1993 to 1999. A Diplomate of the American Board of Toxicology and Honorary Diplomat of the American Veterinary Epidemiology Society, Dr. Schwetz was acting Director of the Environmental Toxicology Program at the National Institutes of Health’s National Institute of Environmental Health Sciences (NIEHS) in Research Triangle Park, NC, before coming to the FDA in 1993. He was also the Associate Director of the National Toxicology Program there. Dr. Schwetz is an elected member of the National Academy of Sciences Institute of Medicine and is a member of the Society of Toxicology (SOT) and the National Capital Area Chapter of the SOT, the American Veterinary Medical Association, the Teratology Society, the Behavioral Teratology Society, and the Society of Toxicologic Pathology (honorary). In addition to numerous other awards during his career, Dr. Schwetz received the U.S. Government’s 1998 Meritorious Executive Presidential Rank Award. He received the Distinguished Service Award of the American College of Toxicology in 2000 and the Merit Award of the Society of Toxicology in 2002.

LOUIS SHERWOOD, M.D. retired on April 1, 2002 after ten years as Senior Vice President for Medical and Scientific Affairs in the U.S. Human Health Division of Merck & Co. He now works as an independent consultant and also holds appointments as Adjunct Professor of Medicine at the University of Pennsylvania and Visiting Professor of Medicine at the Albert Einstein College of Medicine. In his previous position, Dr. Sherwood served as Merck’s Chief Medical Officer for the U.S. and was responsible for all medical activities in the U.S. market, including the Clinical Development program, Outcomes Research and Management, Medical Services, Academic and Professional Affairs and the Medical Directors in various regions of the country. Dr. Sherwood joined the Merck Sharp & Dohme International Division in 1987 as Senior Vice President and in 1989, he moved to the Merck Research Laboratories, serving for three years as Executive Vice President, Worldwide Development, where he was in charge of new drug development during a very productive R&D period.

HAROLD SLAVKIN, D.D.S. is the Dean and G. Donald Marian James Montgomery Professor of Dentistry at the School of Dentistry, University of Southern California. He was previously the director of the National Institute of Dental and Craniofacial Research. He received his undergraduate degree and his DDS from the University of Southern California. Before joining the National Institutes of Health, Dr. Slavkin was director of the Southern California Center for Craniofacial Molecular Biology. In addition, he taught molecular biology at the graduate level and biochemistry and nutrition at the University of Southern California School of Dentistry. He has published 260 peer-reviewed papers and 107 book chapters. Dr. Slavkin’s interests are in craniofacial development and molecular genetics. He is past president of the American Association of Dental Research, and belongs to the American Dental Association, International Society of Developmental Biology, and the International Association for Dental Research. Dr. Slavkin is a member of the Institute of Medicine.

NANCY S. SUNG, Ph.D. is a Program Officer with the Burroughs Wellcome Fund. She oversees BWF Interfaces in Science programs, Innovation Awards in Functional Genomics (previous program), and Clinical Scientist Awards in Translational Research. Dr. Sung has also focused on building collaborations among other private foundations, government agencies, and professional societies who share BWF’s interests in strengthening training and career pathways for researchers in the clinical research and physical/computational biology areas. Dr. Sung received her undergraduate degree from the University of Pennsylvania and a Ph.D. in Microbiology and Immunology from the University of North Carolina at Chapel Hill. Her research has focused on gene regulation in Epstein-Barr virus and its link to nasopharyngeal carcinoma, which is endemic to southern China. Prior to joining the Fund’s staff in 1997, Dr. Sung was a visiting fellow at the Chinese Academy of Preventive Medicine’s Institute of Virology in Beijing, with the support of the WHO and the NIH. Her research interests are in the area of environmentally enhanced genetic susceptibility to cancer.

REED V. TUCKSON, M.D. is Senior Vice President of Consumer Health and Medical Care Advancement at UnitedHealth Group. He is a graduate of Howard University and Georgetown University School of Medicine. He has served as Senior Vice President, Professional Standards, for the American Medical Association (AMA). He is former President of the Charles R. Drew University of Medicine and Science in Los Angeles, has served as Senior Vice President for Programs of the March of Dimes Birth Defects Foundation, and has served as the Commissioner of Public Health for the District of Columbia. He is a member of Institute of Medicine of the National Academy of Sciences and serves as a member of the Secretary of Health and Human Services’ Advisory Committee on Genetics, Health and Society and has held a number of other federal appointments, including cabinet level advisory committees on health reform, infant mortality, children’s health, violence, and radiation testing.

SEAN TUNIS, M.D., M.Sc. is the Acting Deputy Director of the Office of Clinical Standards and Quality (OCSQ) and Acting Chief Clinical Officer at the Centers for Medicare and Medicaid Services (CMS). OCSQ makes evidence-based national coverage policies, sets quality standards for Medicare and Medicaid providers, leads CMS’s quality measurement and improvement activities, and manages Medicare’s Peer Review Program. As Acting Chief Clinical Officer, Dr. Tunis works on overall Agency clinical policy and purchasing initiatives. Dr. Tunis was previously the Director of the Coverage and Analysis Group within OCSQ. Prior to joining CMS, Dr. Tunis was a Senior Research Scientist with The Lewin Group where he led the design and conduct of prospective comparative effectiveness studies. Dr. Tunis also served as the Director of the Health Program at the Congressional Office of Technology Assessment and as a health policy advisor to the U.S. Senate Committee on Labor and Human Resources, where he participated in policy development regarding pharmaceutical and device regulation. Dr. Tunis holds an adjunct faculty position in the Department of Medicine at the Johns Hopkins School of Medicine, and practices as an Emergency Room physician in Baltimore, Maryland. He received a B.S. degree in History of Science from Cornell University, and a medical degree and masters in Health Services Research from Stanford University. Dr. Tunis did his residency training at UCLA and the University of Maryland in Emergency Medicine and Internal Medicine, and is board-certified in Internal Medicine.

ROY E. TWYMAN, M.D. - Bio unavailable

FRANCES M. VISCO, J.D. has served as President of the National Breast Cancer Coalition (NBCC), an organization dedicated to eradicating breast cancer through action and advocacy, since its inception in 1991. Ms. Visco is a two-term member of William Clinton's Cancer Panel, Chairwoman of the National Action Plan on Breast Cancer, and Chairwoman of the Integration Panel of the Department of Defense Peer-reviewed Breast Cancer Research Program. Following her own successful battle with breast cancer, she began her crusade as a breast cancer activist with the Linda Creed Breast Cancer Foundation. Prior to joining NBCC in 1991, she was a commercial litigator and partner at the law firm of Cohen, Shapiro, Polisher, Shiekman & Cohen in Philadelphia. She continues to serve on the Board of the Foundation and is active in many of its programs. Ms. Visco graduated from St. Joseph's University and Villanova Law School. She currently is serving on the National Cancer Policy Board.

SUSAN WEINER, Ph.D. is President and founder of The Children's Cause, Inc., a nonprofit organization dedicated to childhood cancer patients and their families. Dr. Weiner received her Ph.D. in developmental psychology at Columbia University. Prior to The Children's Cause, Dr. Weiner was executive director of the Children's Brain Tumor Foundation for three years, and she remains a board member. Dr. Weiner also currently serves on the boards of the North American Brain Tumor Coalition and Mary McDowell Center for Learning, an independent special education elementary school. She is also a consultant to the Children's Oncology Group. Other ongoing committee involvements include the NCI Pediatric Brain Tumor Consortium, the Child and Adolescent Health Measurement Initiative of the Foundation for Accountability and the National Center for Quality Assurance, and the Cancer Leadership Council. Dr. Weiner has published papers on issues relating to pediatric cancer and its impact on families. She is a member of the American Psychological Association, Council for Exceptional Children, and the New York Academy of Sciences.

MICHAEL WELCH, Ph.D. is Professor of Radiology, Co-Director of the Division of Radiology Sciences of The Edward Mallinckrodt Institute of Radiology, and is Professor of Molecular Biology and Pharmacology at Washington University School of Medicine. He received his B.A. and M.A. degrees in Natural Sciences from Cambridge University and his Ph.D. degree in Radiochemistry at the University of London. Dr. Welch has published several books, numerous journal articles, and book chapters in the area of radiology. Dr. Welch is a member of the Institute of Medicine.